Document is current
Any future updates will be listed below
-
Authors
Lu, Lina https://orcid.org/0000-0001-9395-242X
Pichet Binette, Alexa
Hristovska, Ines
Janelidze, Shorena https://orcid.org/0000-0003-2869-8378
Smets, Bart
Cumplido-Mayoral, Irene
Vasanthakumar, Aparna
Milkovich, Britney
,
An, Lijun https://orcid.org/0000-0003-1030-4625
Ossenkoppele, Rik
Krish, Varsha
Imam, Farhad https://orcid.org/0000-0003-2854-2568
Palmqvist, Sebastian https://orcid.org/0000-0002-9267-1930
Vogel, Jacob W. https://orcid.org/0000-0001-6394-9940
Stomrud, Erik
Hansson, Oskar https://orcid.org/0000-0001-8467-7286
Mattsson-Carlgren, Niklas https://orcid.org/0000-0002-8885-7724
-
Funding
Funding for this research was provided by:
Region Skåne (2025-2026-2024-2028)
Alzheimer's Association (SG-231061717)
Alzheimer's Association (ZEN 24-I 069572)
- License Information
-
More Information
Article History
Received: 3 October 2025
Accepted: 2 April 2026
First Online: 15 May 2026
Competing interests
: N.M.-C. has received speaker/consultancy fees from Biogen, BioArctic, Eli Lilly, and Owkin and Merck. O.H. is an employee of Lund University and Eli Lilly. S.P. has acquired research support (for the institution) from ki elements/ADDF and Avid. In the past 3 years, he has received consultancy/speaker’s fees from Novo Nordisk, BioArctic, Biogen, Esai, Lilly, and Roche. R.O. is currently a full-time employee of Eli Lilly and Company. His contribution to the work presented in this manuscript was performed as an employee of Amsterdam University Medical Centers and Lund University. R.O. has received research funding/support from the European Research Council, ZonMw, Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO), National Institute of Health, Alzheimer Association, Alzheimer Nederland, Stichting Dioraphte, Cure Alzheimer’s fund, Health Holland, ERA PerMed, Alzheimerfonden, Hjarnfonden, Avid Radiopharmaceuticals, Janssen Research & Development, Roche, Quanterix and Optina Diagnostics; he has given lectures in symposia sponsored by GE Healthcare, received speaker fees from Springer, and was an advisory board/steering committee member for Asceneuron, Biogen, Johnson & Johnson, and Bristol Myers Squibb. All the aforementioned has been paid to Amsterdam University Medical Centers and Lund University. B.M. and A.V. are employees of AbbVie. B.S. is an employee of Johnson & Johnson. J.W.V. has received advisory fees from Manifest Technologies within the past 2 years. The remaining authors declare no competing interests.
